Related Experiment Video
Updated: Jul 9, 2026

07:09
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Down modulation of human TLR3 function by a monoclonal antibody
Karen E Duffy1, Roberta J Lamb, Lani R San Mateo
1Discovery Research, Centocor Research and Development, Inc., Malvern, PA 19355, USA. kduffy@cntus.jnj.com
Cellular Immunology
|December 1, 2007
Summary
A new monoclonal antibody (mAb CNTO2424) neutralizes Toll-like receptor 3 (TLR3) signaling. This antibody blocks inflammatory cytokine production and interferes with key TLR3 pathways, offering a tool to study innate immunity.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Toll-like receptors (TLRs) are crucial pattern-recognition receptors in the innate immune system.
- Toll-like receptor 3 (TLR3) recognizes various ligands, including viral dsRNA and synthetic analogs like poly(I:C).
Purpose of the Study:
- To generate and characterize a novel monoclonal antibody (mAb CNTO2424) targeting the extracellular domain of human TLR3.
- To investigate the functional impact of mAb CNTO2424 on TLR3-mediated signaling and cytokine production.
Main Methods:
- Generation of a conformation-dependent monoclonal antibody (mAb CNTO2424) against human TLR3.
- Assessment of mAb CNTO2424's effect on poly(I:C)-induced cytokine production (IL-6, IL-8, MCP-1, RANTES, IP-10) in human lung epithelial cells.
- Analysis of TLR3-dependent signaling pathways (NF-kappaB, IRF-3/ISRE, p38 MAPK) interference by mAb CNTO2424.
Main Results:
- mAb CNTO2424 recognizes the extracellular domain of human TLR3 in a conformation-dependent manner.
- CNTO2424 significantly down-regulates poly(I:C)-induced production of key inflammatory cytokines and chemokines.
- The antibody effectively interferes with established TLR3 signaling cascades, including NF-kappaB, IRF-3/ISRE, and p38 MAPK pathways.
Conclusions:
- The development of mAb CNTO2424 provides a valuable neutralizing tool for studying TLR3 function.
- This antibody can elucidate TLR3 signaling mechanisms and potential cross-talk with other molecular pathways in innate immunity.

